neuromodulator


Also found in: Dictionary, Medical, Wikipedia.

neuromodulator

[‚nu̇r·ō′mäj·ə‚lād·ər]
(neuroscience)
A chemical agent that is released by a neurosecretory cell and acts on other neurons in a local region of the central nervous system by modulating their response to neurotransmitters.
References in periodicals archive ?
a biotechnology company developing a new category of high-performance neuromodulators for use in treating aesthetic and therapeutic conditions, announced the appointment of Chris Nolet to the companys Board of Directors.
Revance is a clinical-stage biotechnology company focused on the development, manufacturing, and commercialization of novel neuromodulators for multiple aesthetic and therapeutic indications.
H Huang, and Department of Psychology, Nanjing University of Chinese Medicine, Nanjing, 210023 China, "Differentiation of primary emotions through neuromodulators: review of literature," International Journal of Neurology Research, vol.
In recent decades, hydrogen sulfide (H[sub]2S) has been identified as a novel endogenous vasodilator and neuromodulator due to its antioxidation capacity.
Zinc: Zinc homeostasis in the brain is closely associated with neuronal activity, and considered an endogenous neuromodulator in synaptic neurotransmission.
According to the researchers, this behavior of the nucleus accumbens neurons could be caused by a neuromodulator called adenosine.
The molecular mechanisms involved in this neuromodulator effect of H2S are not clear, although the effects, both exogenous and endogenous, of H2S in primarily cultured medullary neurons elevate [[Ca2+].sub.i] levels, mainly by increasing the calcium influx and mobilizing intracellular [Ca.sup.2+] stores from ER from primarily cultured rat medullary neurons.
"Neuromodulator" brain chemicals, which pace neuron activity, can directly wake the brain or lull it to sleep by changing ion concentrations.
This is a randomized, controlled, blind, crossover trial comparing cycling versus continuous programming of a sacral neuromodulator in women diagnosed with overactive bladder (OAB).
(NYSE MKT: MDGN) has acquired neuroFix Therapeutics, LLC, the developer of NFC-1, a first-in-class, non-stimulant metabotropic glutamate receptor (mGluR) neuromodulator, the company said.